Using the Kaplan-Meier plotter tool to analyze the survival data, we noted a correlation between high TWF1 expression level and poor OS, FP (First progression) and PPS (Post-progression survival) prognosis for gastric cancer and lung cancer, poor OS for ovarian cancer, poor RFS (Relapse-free survival) and PPS for breast cancer, and poor PFS (Progression-free survival) for liver cancer (Figure S6). Here, TWF1 is linked to breast cancer.